Table 1. Effects of therapeutic oral administration of BBG9-1 on concentrations of acetic acid and L-lactic acid and pH in contents of the small intestine and large intestine.
Non-RV | RV-Control | RV-BBG9-1 | ||
---|---|---|---|---|
Small intestinal contents | Acetic acid (mg/mL) | 178 ± 13 | 251 ± 7** | 240 ± 11** |
L-lactic acid (mg/mL) | 433 ± 34 | 651 ± 36* | 512 ± 68 | |
pH | 6.19 ± 0.03 | 6.40 ± 0.04** | 6.43 ± 0.02** | |
Cecum and colonic contents | Acetic acid (mg/mL) | 309 ± 57 | 317 ± 38 | 399 ± 31 |
L-lactic acid (mg/mL) | 344 ± 70 | 841 ± 55* | 1262 ± 155**, # | |
pH | 5.75 ± 0.08 | 6.23 ± 0.15 | 5.79 ± 0.21 |
Oral administration of BBG9-1 and inoculation of RV were performed as described in the legend of Fig 2. Contents of the small intestine and contents of the cecum and colon were harvested 2 days after infection. Data are shown as means ± S.E. (n = 6 pups for each group).
*p < 0.05.
**p < 0.01 compared with the Non-RV group.
#p<0.05 with the RV-Control group by the Tukey-Kramer test or Steel Dwass test.